BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37399248)

  • 21. Single-cell mutation analysis of clonal evolution in myeloid malignancies.
    Miles LA; Bowman RL; Merlinsky TR; Csete IS; Ooi AT; Durruthy-Durruthy R; Bowman M; Famulare C; Patel MA; Mendez P; Ainali C; Demaree B; Delley CL; Abate AR; Manivannan M; Sahu S; Goldberg AD; Bolton KL; Zehir A; Rampal R; Carroll MP; Meyer SE; Viny AD; Levine RL
    Nature; 2020 Nov; 587(7834):477-482. PubMed ID: 33116311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.
    Lundberg P; Karow A; Nienhold R; Looser R; Hao-Shen H; Nissen I; Girsberger S; Lehmann T; Passweg J; Stern M; Beisel C; Kralovics R; Skoda RC
    Blood; 2014 Apr; 123(14):2220-8. PubMed ID: 24478400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal evolution of acute myeloid leukemia highlighted by latest genome sequencing studies.
    Zhang X; Lv D; Zhang Y; Liu Q; Li Z
    Oncotarget; 2016 Sep; 7(36):58586-58594. PubMed ID: 27474172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Molecular Insights into Leukemic Evolution of Myeloproliferative Neoplasms: A Single Cell Perspective.
    Rontauroli S; Carretta C; Parenti S; Bertesi M; Manfredini R
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hitting the brakes on accelerated and blast-phase myeloproliferative neoplasms: current and emerging concepts.
    Bewersdorf JP; Rampal RK
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):218-224. PubMed ID: 36485103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer.
    Barbui T; Gavazzi A; Sciatti E; Finazzi MC; Ghirardi A; Carioli G; Carobbio A
    Curr Hematol Malig Rep; 2023 Aug; 18(4):105-112. PubMed ID: 37221411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase.
    Cherington C; Slack JL; Leis J; Adams RH; Reeder CB; Mikhael JR; Camoriano J; Noel P; Fauble V; Betcher J; Higgins MS; Gillette-Kent G; Tremblay LD; Peterson ME; Olsen JJ; Tibes R; Mesa RA
    Leuk Res; 2012 Sep; 36(9):1147-51. PubMed ID: 22578777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm.
    Tefferi A; Alkhateeb H; Gangat N
    Blood Cancer J; 2023 Jul; 13(1):108. PubMed ID: 37460550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients.
    Borsi E; Vigliotta I; Poletti A; Mazzocchetti G; Solli V; Zazzeroni L; Martello M; Armuzzi S; Taurisano B; Kanapari A; Pistis I; Zamagni E; Pantani L; Rocchi S; Mancuso K; Tacchetti P; Rizzello I; Rizzi S; Dan E; Sinigaglia B; Cavo M; Terragna C
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms.
    Palomo L; Meggendorfer M; Hutter S; Twardziok S; Ademà V; Fuhrmann I; Fuster-Tormo F; Xicoy B; Zamora L; Acha P; Kerr CM; Kern W; Maciejewski JP; Solé F; Haferlach C; Haferlach T
    Blood; 2020 Oct; 136(16):1851-1862. PubMed ID: 32573691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukemic Transformation of Myeloproliferative Neoplasms: Therapeutic and Genomic Considerations.
    Li B; Mascarenhas JO; Rampal RK
    Curr Hematol Malig Rep; 2018 Dec; 13(6):588-595. PubMed ID: 30353413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases.
    Gangat N; Guglielmelli P; Szuber N; Begna KH; Patnaik MM; Litzow MR; Al-Kali A; Foran JM; Palmer JM; Alkhateeb H; Elliott MA; Hanson CA; Pardanani A; Mannelli F; Vannucchi AM; Tefferi A
    Am J Hematol; 2021 Jul; 96(7):781-789. PubMed ID: 33844862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-cell analysis reveals selection of TP53-mutated clones after MDM2 inhibition.
    Maslah N; Verger E; Giraudier S; Chea M; Hoffman R; Mascarenhas J; Cassinat B; Kiladjian JJ
    Blood Adv; 2022 May; 6(9):2813-2823. PubMed ID: 35030630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clonal evolution of myeloid malignancies].
    Kon A
    Rinsho Ketsueki; 2020; 61(9):1120-1129. PubMed ID: 33162507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerated and blast phase myeloproliferative neoplasms.
    Saliba AN; Gangat N
    Best Pract Res Clin Haematol; 2022 Jun; 35(2):101379. PubMed ID: 36333070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular basis and clonal evolution of myeloproliferative neoplasms.
    Cleary C; Kralovics R
    Clin Chem Lab Med; 2013 Oct; 51(10):1889-96. PubMed ID: 23729579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms.
    Pardanani A; Lasho TL; Finke CM; Mai M; McClure RF; Tefferi A
    Leukemia; 2010 Jun; 24(6):1146-51. PubMed ID: 20410924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2
    Todisco G; Creignou M; Gallì A; Guglielmelli P; Rumi E; Roncador M; Rizzo E; Nannya Y; Pietra D; Elena C; Bono E; Molteni E; Rosti V; Catricalá S; Sarchi M; Dimitriou M; Ungerstedt J; Vannucchi AM; Hellström-Lindberg E; Ogawa S; Cazzola M; Malcovati L
    Leukemia; 2021 Aug; 35(8):2371-2381. PubMed ID: 33349666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clonal architecture of chronic myelomonocytic leukemias.
    Itzykson R; Kosmider O; Renneville A; Morabito M; Preudhomme C; Berthon C; Adès L; Fenaux P; Platzbecker U; Gagey O; Rameau P; Meurice G; Oréar C; Delhommeau F; Bernard OA; Fontenay M; Vainchenker W; Droin N; Solary E
    Blood; 2013 Mar; 121(12):2186-98. PubMed ID: 23319568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.